|
| | Publication Year | Title | Author(s) |
| 1 | Aug-2021 | A vaccination update for rheumatologists-SARS-CoV-2, influenza and herpes zoster. | Wong, Peter K K; Lahiri, Manjari; Lye, David Chien; Johnson, Douglas; Charles, Patrick G P |
| 2 | 21-Apr-2010 | ACE inhibition reduces infarction in normotensive but not hypertensive rats: correlation with cortical ACE activity. | Porritt, Michelle J; Chen, Michelle; Rewell, Sarah S J; Dean, Rachael G; Burrell, Louise M ; Howells, David William |
| 3 | 3-Jan-2008 | ACE2 and AT4R are present in diseased human blood vessels. | Zulli, Anthony; Burrell, Louise M ; Buxton, Brian F ; Hare, David L |
| 4 | 2007 | ACE2 and diabetic complications. | Dean, Rachael G; Burrell, Louise M |
| 5 | 1-Jan-2013 | The ACE2 gene: its potential as a functional candidate for cardiovascular disease. | Burrell, Louise M ; Harrap, Stephen B; Velkoska, Elena; Patel, Sheila K |
| 6 | 6-May-2004 | ACE2, a new regulator of the renin-angiotensin system. | Burrell, Louise M ; Johnston, Colin I; Tikellis, Christos; Cooper, Mark E |
| 7 | 22-Jun-2013 | Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis. | Grace, Josephine A ; Klein, Sabine; Herath, Chandana B; Granzow, Michaela; Schierwagen, Robert; Masing, Noemi; Walther, Thomas; Sauerbruch, Tilman; Burrell, Louise M ; Angus, Peter W ; Trebicka, Jonel |
| 8 | 25-Jan-2008 | Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression. | Burchill, Luke J; Velkoska, Elena; Dean, Rachael G; Lew, R A; Smith, A I; Levidiotis, Vicki; Burrell, Louise M |
| 29 | 27-Feb-2017 | Adverse cardiac effects of exogenous angiotensin 1-7 in rats with subtotal nephrectomy are prevented by ACE inhibition | Burrell, Louise M ; Gayed, Daniel; Griggs, Karen; Patel, Sheila K ; Velkoska, Elena |
| 30 | 15-Aug-2013 | Age adjusted Charlson Co-morbidity Index is an independent predictor of mortality over long-term follow-up in infective endocarditis. | Lu, K J; Kearney, Leighton G ; Ord, M; Jones, Elizabeth F ; Burrell, Louise M ; Srivastava, Piyush M |
| 31 | 14-Dec-2012 | Age-dependent regulation of renal vasopressin V(1A) and V₂ receptors in rats with genetic hypertension: implications for the treatment of hypertension. | Burrell, Louise M ; Risvanis, John; Dean, Rachael G; Patel, Sheila K ; Velkoska, Elena; Johnston, Colin I |
| 32 | 18-Feb-2009 | Angiotensin converting enzyme 2 (ACE2) activity in fetal calf serum: implications for cell culture research. | Lubel, J S; Herath, C B; Velkoska, Elena; Casley, David J; Burrell, Louise M ; Angus, Peter W |
| 33 | 1-Aug-2017 | Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling | Walters, Tomos E; Kalman, Jonathan M; Patel, Sheila K ; Mearns, Megan; Velkoska, Elena; Burrell, Louise M |
| 34 | 1-Jul-1993 | Angiotensin converting enzyme inhibitors in perspective: an update. | Burrell, Louise M ; Johnston, Colin I |
| 35 | 1-Jun-1997 | Angiotensin II receptor antagonists. Potential in elderly patients with cardiovascular disease. | Burrell, Louise M ; Johnston, Colin I |
| 36 | 16-Nov-2022 | Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial. | Jardine, Meg J; Kotwal, Sradha S; Bassi, Abhinav; Hockham, Carinna; Jones, Mark; Wilcox, Arlen; Pollock, Carol; Burrell, Louise M ; McGree, James; Rathore, Vinay; Jenkins, Christine R; Gupta, Lalit; Ritchie, Angus; Bangi, Ashpak; D'Cruz, Sanjay; McLachlan, Andrew J; Finfer, Simon; Cummins, Michelle M; Snelling, Thomas; Jha, Vivekanand |
| 37 | Aug-2020 | Angiotensin- neprilysin inhibitors: should we initiate them in hospital for patients with acute decompensated heart failure? | Grigg, Samuel E |
| 38 | 1-Apr-2011 | Angiotensin-(1-7) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy. | Velkoska, Elena; Dean, Rachael G; Griggs, Karen; Burchill, Luke J; Burrell, Louise M |
| 39 | 18-Oct-2012 | Angiotensin-(1-7) reduces the perfusion pressure response to angiotensin II and methoxamine via an endothelial nitric oxide-mediated pathway in cirrhotic rat liver. | Herath, Chandana B; Mak, Kai; Burrell, Louise M ; Angus, Peter W |
| 40 | 14-Sep-2009 | Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat. | Lubel, John S; Herath, Chandana B; Tchongue, Jorge; Grace, Josephine A ; Jia, Zhiyuan; Spencer, Karen; Casley, David J; Crowley, Peter; Sievert, William; Burrell, Louise M ; Angus, Peter W |
